Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population

Autor: Lisa Shigematsu, Ryusei Kimura, Hideki Terai, Yu Mimura, Daisuke Ito, Shogyoku Bun, Ho Namkoong, Takanori Asakura, Shotaro Chubachi, Katsunori Masaki, Keiko Ohgino, Jun Miyata, Ichiro Kawada, Makoto Ishii, Ryo Takemura, Soichiro Ueda, Takashi Yoshiyama, Hiroyuki Kokuto, Tatsuya Kusumoto, Ayano Oashi, Masayoshi Miyawaki, Fumitake Saito, Tetsuo Tani, Kota Ishioka, Saeko Takahashi, Morio Nakamura, Yasunori Sato, Koichi Fukunaga

Publikováno v: Annals of Clinical and Translational Neurology, Vol 11, Iss 8, Pp 2188-2200 (2024)

Abstract Objective To reveal the clinical features and assess risk factors linked to brain fog and its societal implications, including labor productivity, providing valuable insights for the future care of individuals who have experienced coronaviru

Externí odkaz: https://doaj.org/article/5e80c895e8a84b368f1fba53de0b9dd9

Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)

Autor: Kenjiro Namikawa, Takamichi Ito, Shusuke Yoshikawa, Koji Yoshino, Yukiko Kiniwa, Shuichi Ohe, Taiki Isei, Tatsuya Takenouchi, Hiroshi Kato, Satoru Mizuhashi, Satoshi Fukushima, Yosuke Yamamoto, Takashi Inozume, Yasuhiro Fujisawa, Osamu Yamasaki, Yasuhiro Nakamura, Jun Asai, Takeo Maekawa, Takeru Funakoshi, Shigeto Matsushita, Eiji Nakano, Kohei Oashi, Junji Kato, Hisashi Uhara, Takuya Miyagawa, Hiroshi Uchi, Naohito Hatta, Keita Tsutsui, Taku Maeda, Taisuke Matsuya, Hiroto Yanagisawa, Ikko Muto, Mao Okumura, Dai Ogata, Naoya Yamazaki

Publikováno v: Cancer Medicine, Vol 12, Iss 17, Pp 17967-17980 (2023)

Abstract Background Anti‐PD‐1‐based immunotherapy is considered a preferred first‐line treatment for advanced BRAF V600‐mutant melanoma. However, a recent international multi‐center study suggested that the efficacy of immunotherapy is po

Externí odkaz: https://doaj.org/article/7bd38e76e920444a8356acd6025d9a4c

Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study

Autor: Terai, Hideki, Ishii, Makoto, Takemura, Ryo, Namkoong, Ho, Shimamoto, Kyoko, Masaki, Katsunori, Tanosaki, Takae, Chubachi, Shotaro, Matsuyama, Emiko, Hayashi, Reina, Shimada, Takashi, Shigematsu, Lisa, Ito, Fumimaro, Kaji, Masanori, Takaoka, Hatsuyo, Kurihara, Momoko, Nakagawara, Kensuke, Tomiyasu, Saki, Sasahara, Kotaro, Saito, Ayaka, Otake, Shiro, Azekawa, Shuhei, Okada, Masahiko, Fukushima, Takahiro, Morita, Atsuho, Tanaka, Hiromu, Sunata, Keeya, Asaoka, Masato, Nishie, Miyuki, Shinozaki, Taro, Ebisudani, Toshiki, Akiyama, Yuto, Mitsuishi, Akifumi, Nakayama, Shingo, Ogawa, Takunori, Sakurai, Kaori, Irie, Misato, Yagi, Kazuma, Ohgino, Keiko, Miyata, Jun, Kabata, Hiroki, Ikemura, Shinnosuke, Kamata, Hirofumi, Yasuda, Hiroyuki, Kawada, Ichiro, Kimura, Ryusei, Kondo, Masahiro, Iwasaki, Toshiki, Ishida, Noriyuki, Hiruma, Gaku, Miyazaki, Naoki, Ishibashi, Yoshiki, Harada, Sei, Fujita, Takanori, Ito, Daisuke, Bun, Shogyoku, Tabuchi, Hajime, Kanzaki, Sho, Shimizu, Eisuke, Fukuda, Keitaro, Yamagami, Jun, Kobayashi, Keigo, Hirano, Toshiyuki, Inoue, Takashi, Haraguchi, Mizuha, Kagyo, Junko, Shiomi, Tetsuya, Lee, Ho, Sugihara, Kai, Omori, Nao, Sayama, Koichi, Otsuka, Kengo, Miyao, Naoki, Odani, Toshio, Watase, Mayuko, Mochimaru, Takao, Satomi, Ryosuke, Oyamada, Yoshitaka, Masuzawa, Keita, Asakura, Takanori, Nakayama, Sohei, Suzuki, Yusuke, Baba, Rie, Okamori, Satoshi, Arai, Daisuke, Nakachi, Ichiro, Kuwahara, Naota, Fujiwara, Akiko, Oakada, Takenori, Ishiguro, Takashi, Isosno, Taisuke, Makino, Yasushi, Mashimo, Shuko, Kaido, Tatsuya, Minematsu, Naoto, Ueda, Soichiro, Minami, Kazuhiro, Hagiwara, Rie, Manabe, Tadashi, Fukui, Takahiro, Funatsu, Yohei, Koh, Hidefumi, Yoshiyama, Takashi, Kokuto, Hiroyuki, Kusumoto, Tatsuya, Oashi, Ayano, Miyawaki, Masayoshi, Saito, Fumitake, Tani, Tetsuo, Ishioka, Kota, Takahashi, Saeko, Nakamura, Morio, Harada, Norihiro, Sasano, Hitoshi, Goto, Ai, Kusaka, Yu, Ohba, Takehiko, Nakano, Yasushi, Nishio, Kazumi, Nakajima, Yukiko, Suzuki, Shoji, Yoshida, Shuichi, Tateno, Hiroki, Kodama, Nobuhiro, Shunsuke, Maeda, Sakamoto, Satoshi, Okamoto, Masaki, Nagasaki, Yoji, Umeda, Akira, Miyagawa, Kazuya, Shimada, Hisato, Hagimura, Kazuto, Nagashima, Kengo, Sato, Toshiro, Sato, Yasunori, Hasegawa, Naoki, Takebayashi, Toru, Nakahara, Jin, Mimura, Masaru, Ogawa, Kaoru, Shimmura, Shigeto, Negishi, Kazuno, Tsubota, Kazuo, Amagai, Masayuki, Goto, Rei, Ibuka, Yoko, Kitagawa, Yuko, Kanai, Takanori, Fukunaga, Koichi

Publikováno v: In Respiratory Investigation November 2023 61(6):802-814

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)

Autor: Kohei Oashi, Taro Shibata, Kenjiro Namikawa, Akira Takahashi, Kenji Yokota, Eiji Nakano, Yukiko Teramoto, Arata Tsutsumida, Taku Maeda, Naoya Yamazaki, the Dermatologic Oncology Group of the Japan Clinical Oncology Group

Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)

Abstract Background Paclitaxel is a standard of care for patients with primary cutaneous angiosarcoma of the scalp and face. However, no standard second-line treatment for paclitaxel-resistant patients has ever been established. Since primary cutaneo

Externí odkaz: https://doaj.org/article/c3bb360c0923402db2775706b66092dc